Is EKSO BIONICS HOLDINGS, INC. (EKSO) Halal?

NASDAQ Healthcare United States $36M
✗ NOT HALAL
Confidence: 90/100
EKSO BIONICS HOLDINGS, INC. (EKSO) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 15.16% exceeds the 5% threshold allowed under AAOIFI. EKSO BIONICS HOLDINGS, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 11.5%
/ 30%
2.9%
/ 30%
18.0%
/ 30%
15.16%
/ 5%
✗ NOT HALAL
DJIM 11.5%
/ 33%
2.9%
/ 33%
18.0%
/ 33%
15.16%
/ 5%
✗ NOT HALAL
MSCI 23.1%
/ 33%
5.8%
/ 33%
36.3%
/ 33%
15.16%
/ 5%
✗ NOT HALAL
S&P 11.5%
/ 33%
2.9%
/ 33%
18.0%
/ 33%
15.16%
/ 5%
✗ NOT HALAL
FTSE 23.1%
/ 33%
5.8%
/ 33%
36.3%
/ 50%
15.16%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-4.91
P/B Ratio
4.0
EV/EBITDA
-3.6
EV: $40M
Revenue
$13M
Growth: -38.3%
Beta
0.8
Average volatility
Current Ratio
1.6

Profitability

Gross Margin 53.5%
Operating Margin -119.7%
Net Margin -91.4%
Return on Equity (ROE) -107.6%
Return on Assets (ROA) -33.6%

Cash Flow & Balance Sheet

Operating Cash Flow-$12M
Free Cash Flow-$12M
Total Debt$5M
Debt-to-Equity51.4
Current Ratio1.6
Total Assets$20M

Price & Trading

Last Close$10.90
50-Day MA$10.14
200-Day MA$5.96
Avg Volume2.2M
Beta0.8
52-Week Range
$2.73
$13.50

About EKSO BIONICS HOLDINGS, INC. (EKSO)

CEO
Mr. Scott G. Davis
Employees
50
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$36M
Currency
USD

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is EKSO BIONICS HOLDINGS, INC. (EKSO) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), EKSO BIONICS HOLDINGS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is EKSO BIONICS HOLDINGS, INC.'s debt ratio?

EKSO BIONICS HOLDINGS, INC.'s debt ratio is 11.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 23.1%.

What are EKSO BIONICS HOLDINGS, INC.'s key financial metrics?

EKSO BIONICS HOLDINGS, INC. has a market capitalization of $36M, and revenue of $13M. The company maintains a gross margin of 53.5% and a net margin of -91.4%. Return on equity stands at -107.6%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.